$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Abstract AI-Helper 아이콘AI-Helper

Objectives The purpose of this study was to evaluate anti-obesity effect of Galgeuntang (gegentang) and elucidate the effect of it on gene expression related to obesity. Methods The experiments were performed with the use of Diet-Induced Obese mice. They were grouped NC (normal control), HFD (high f...

주제어

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

문제 정의

  • 갈근탕이 비만에 치료에 일정한 효과가 있을 것으로 사료되는 바 본 연구에서는 갈근탕의 비만 치료제로서 가능성을 알아보기 위하여 고지방식이로 비만이 유발된 쥐의 갈근탕 투여 전후의 체중 변화 및 비만 관련 유전자 발현변화에 대해 살펴보고 얻은 결과를 보고하고자 한다.
본문요약 정보가 도움이 되었나요?

질의응답

핵심어 질문 논문에서 추출한 답변
갈근탕의 구성 요소는 무엇인가? 갈근탕은 갈근, 마황, 계지, 작약, 감초, 생강, 대추로 구성된 복합 처방으로서 감기나 두통, 해열 및 진경 등에 사용되고 있으며6) 갈근탕에 대한 기존 연구로는 소염, 해열, 진통 작용7), 아토피 피부염 및 알레르기성 염증관련 연구8), 항산화9) 및 항노화10), 면역조절작용11) 등에 관한 연구가 이루어져왔으나 아직 비만 관련 연구는 많지 않다.
갈근탕은 어떤 병증에 사용되는가? 갈근탕은 갈근, 마황, 계지, 작약, 감초, 생강, 대추로 구성된 복합 처방으로서 감기나 두통, 해열 및 진경 등에 사용되고 있으며6) 갈근탕에 대한 기존 연구로는 소염, 해열, 진통 작용7), 아토피 피부염 및 알레르기성 염증관련 연구8), 항산화9) 및 항노화10), 면역조절작용11) 등에 관한 연구가 이루어져왔으나 아직 비만 관련 연구는 많지 않다.
교감신경 효능제를 통한 자극은 어떤 효과를 야기할 수 있는가? 갈근탕의 또 다른 주요 구성 약재인 마황은 pseudo ephedrine과 methyl ephedrine이 신사구체 분비를 통해 이뇨를 증진시키고6), ephedrine은 간접적으로는 교감신경 내 신경세포 저장 부위에서 내인성 카테콜아민인 dopamine, norepinephrine, epinephrine 등을 분비시켜 교감신경을 자극하며 직접적으로는 α, β 교감신경 효능제로 작용한다. 이러한 교감신경 자극은 혈관수축이나 혈압상승 등의 심혈관계 및 흥분, 각성, 불면 같은 중추신경계에 대한 작용 외에도 發汗, 체중감량효과 등이 있다25).
질의응답 정보가 도움이 되었나요?

참고문헌 (57)

  1. Ministry of Health and Welfare. Korea National Health and Nutrition Examination Survey (KNHANES). 2014. 

  2. Faust IM, Johnson PR, Stern JS, Hirsch J. Diet-induced adipocyte number increase in adult rats-new model of obesity. Am J Physiol 1978;235:E279-86. 

  3. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85-97. 

  4. Hong CR. Inhibitory effect of Cori fructus ethanolic extracts on adipogenesis in 3T3-L1 preadipocytes. Master's degree. Incheon: Inha University. 2009. 

  5. Hwang MJ, Shin HD, Song MY. Literature Review of Herbal Medicines on Treatment of Obesity Since 2000 - Mainly about Ephedra Herba. J Korean Med Obes Res. 2007;7(1):39-54. 

  6. Park YS. Herbal Pharmacology Commentary. Seoul: Academy books, 2002:113, 127, 197-202. 

  7. Yang TK, Kim YB, Chae BY. An Experimental study on the anti-allergic effects, anti-inflammatory action, anti-pyretic action and analgesic action of Galgeun-tang, Gamigalgeun-tang and Geomahwanggalgeun-tang. J Orient Med Surgery, Ophthalmology & Otolaryngology 2002;15(1):76-95. 

  8. Ha HK, Lee JK, Lee MY, Lim HS, Shin HK. Galgeuntang, an Herbal Formula, Ameliorates Atopic Dermatitis esponses in Dust Mite Extract-treated NC/Nga Mice. J Korean Med. 2013;34(4):1-11. 

  9. Kim DR, Kwak GS, Jeong SM, Lee SC and Ha. JU. Comparison of the Antioxidative Abilities of Commercial Gal Geun Tang. J. Korean Soc. Food Sci. Nutr. 2003; 32(5):728-32. 

  10. Shin JM. Screening of Antiaging Compound from Galgeuntang and the Roots of Pueraria thunbergiana Benth. Wonkwang University. 2007. 

  11. Cho DY. Effect of Gal-Geun-Tang on Antigen-Specific Immune Response. Wonkwang University. 2005. 

  12. Kim SB. The effects of proliferation and differentiation on adipocyte 3T3-L1 by prescriptions and herbs of Tae-yang In and Tae-um In. J Sasang Constitut Med. 1998;10(2):533-64. 

  13. Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA. 2003;289(12):1537-45. 

  14. Song MY, Kim HJ. Analysis of Main Single Medicinal Herbs for Anti-Obesity. J Korean Med Obes Res 2013; 13(2):51-7. 

  15. Kang SC, Lee CM, Choi H, Lee JH, Oh JS, Kwak JH, Zee OP. Evaluation of oriental medicinal herbs for estrogenic and antiproliferative activities. Phytother Res. 2006;20 (11):1017-9. 

  16. Shin HJ, Yoo JE, Jung EH, Yoo DY. Effects of Pueraria iobata body weight and gene expression in obese rats muscle with estrogen defieiency. J Orient Gynecol. 2012; 25(3):71-84. 

  17. Yoon KH, Yoon MC, Kim H, Shin SS. Changes in mRNA Expression of Obesity-related Genes by Gyeongshinhae- Gihwan 1(GGT1) in hGHTg (human growth hormone transgenic) obese Female Rats. Korean J. Oriental Physiology & Pathology 2006;20(2):383-7. 

  18. Oh JH, Ahn YJ, Lee HR, Lim HS, Lee HH, Yoon MC, Shin SS. Comparison among GGEx16, GGEx18 and gambitongseong- capsule for anti-obesity gene activity. Kor. J. Herbology 2013;28(2):39-44. 

  19. Ryu HJ, Um MY, Ahn JY, Jung CH, Huh D, Kim TW, and Ha TY. Anti-obesity Effect of Hypsizigus marmoreus in High Fat-fed Mice. J Korean Soc Food Sci Nutr 2011;40(12):1708-14. 

  20. Kim HJ, Hong SY, Heo DS, Yoon IJ, Oh MS. The Inhibitory Effects of Sansayukbokhap- bang (SSYBHB) on the Obese-Mouse Induced High Fat Diet. J Korean Med Obes Res. 2008;8(1):33-49. 

  21. Hwang SJ, Song TW, Oh MS. The inhibitory Effects of Bangpungtongseoung-san on the Obese gene and Obese Inhibitory about Obese-mouse induced by High Fat Diet. J Korean Oriental Med 2006;27(1):11-22. 

  22. Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA et al. Efficacy and Safety of ephedra and ephedrine for weight loss and arthletic performance: a meta-analysis. JAMA. 2003;289(12):1537-45. 

  23. Qi W, Weber CR, Wasland K, Savkovic SD. Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity. BMC Cancer. 2011;11(1):219. 

  24. Kang SC, Lee CM, Choi H, Lee JH, Oh JS, Kwak JH, Zee OP. Evaluation of oriental medicinal herbs for estrogenic and antiproliferative activities. Phytother Res. 2006; 20(11):1017-9. 

  25. Lee KH, Ahn DK, Shin MK, Kim CM. Dictionary of Chinese medicine. Seoul:Jeong Dam Books. 2006:1000, 3081. 

  26. Gregoire FM, Smas CM, Sul HS. Understanding Adipocyte Differentiation. Physiol Rev. 1998;78(3):783-809. 

  27. run RP, Kim JB, Hu E, Altiok S, Spiegelman BM. Adipocyte differentiation: a transcriptional regulatory. Curr. Opin. Cell. Biol. 1996;826-832. 

  28. Gregoire FM, Smas CM. Understanding adipocyte differentiation. Physiol. Rev. 1998; 78:783-809. 

  29. Saitoa T, Abea D and Sekiya K. Flavanone exhibits PPAR ${\gamma}$ ligand activity and enhanced differentiation of 3T3-L1 adipocyte. Biochem. Biophys. Res. Commun. 2009;308:281-5. 

  30. Tontonoz O, Hu E. and Spiegelman BM. Regulation of adipocyte of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr. Opin. Genet. Dev. 1995;5:571-6. 

  31. El-Jack AK, Hamm JK, Pilch PF, Farmar SR. Reconstitution of insulin-sensitive glucose transport in fibroblasts requires expression of both PPAR gamma and C/EBP alpha. J. Biol. Chem. 1999;274:7946-51. 

  32. Fox KE, Fankell DM, Erickson PF, Maika SM, Crossno JT, Klemm DJ. Depletion of cAMP-response element- binding protein/ATF1 inhibits adipogenic conversion of 3T3-L1 cells ectopically expressing CCAAT. enhancer-binding protein (C/EBP) alpha, C.EBP beta, or PPAR gammar 2. J. Biol. Chem. 2006;286:40341-53. 

  33. Hamm JK, Park BH, Farmar SR. A role of C/EBP beta in regulating peroxisome proliferator-activated receptor gamma activity during adipogenesis in 3T3-L1 preadipocyte. J. Biol. Chem. 2001;276:18464-71. 

  34. Cao Z, Umek RM, McKnight SL. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 1991;5:1538-52. 

  35. Long SD, Pekala PH. Lipid mediators of insulin resistance: ceramide signalling down-regulates GLUT4 gene transcription in 3T3-L1 adipocytes. J. Biol. Chem. 1996; 319:179-184. 

  36. Spiegelman BM. "PPAR-gamma: adipogenic regulator and hiazolidinedione receptor," Diabetes, 1998;47(4);507-14. 

  37. El-Jack AK, Hamm JK, Pilch PF, Farmar SR. Reconstitution of insulin-sensitive glucose transport in fibroblasts requires expression of both PPAR gamma and C/EBP alpha. J. Biol. Chem. 1999;274:7946-51. 

  38. Fox KE, Fankell DM, Erickson PF, Maika SM, Crossno JT, Klemm DJ. Depletion of cAMP-response elementbinding protein/ATF1 inhibits adipogenic conversion of 3T3-L1 cells ectopically expressing CAAT.enhancer-binding protein (C/EBP) alpha, C.EBP beta, or PPAR gammar 2. J. Biol. Chem. 2006;286:40341-53. 

  39. Hamm JK, Park BH, Farmar SR. A role of C/EBP beta in regulating peroxisome proliferator-activated receptor gamma activity during adipogenesis in 3T3-L1 preadipocyte. J. Biol. Chem. 2001;276:18464-71. 

  40. Lee JJ, Chun CS, Kin JG, Choi BD. Effect of fasting refeeding on rat adipose tissue lipoprotein lipase activity and lipogenesis: Influence of food restriction during refeeding. J. Korean Soc. Food Sci. Nutr. 2000;29:471-8. 

  41. O'Brien KD, Gordon D, Deeb S, Ferguson M, Chait A. Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques. J. Clin. Invest. 1992;89:1544-50. 

  42. Gimeno RE. Fatty acid transport proteins. Curr Opin Lipidol 2007;18:271-6. 

  43. Holloway GP, Chou CJ, Lally J, Stellingwerff T, Maher AC, Gavrilova O, Haluzik M, Alkhateeb H, Reitman ML and Bonen A. Increasing skeletal muscle fatty acid transport protein 1 (FATP1) targets fatty acids to oxidation and does not predispose mice to diet-induced insulin resistance. Diabetologia 2011;54:1457-67. 

  44. Kim HJ and Lee WJ. Insulin-like Growth Factor-I Induces FATP1 Expression in C2C12 Myotubes. J Life Sci. 2014;24(12):1284-90. 

  45. Bruce CR, Hoy AJ, Turner N, Watt MJ, Allen TL, Carpenter K, Cooney GJ, Febbraio MA, Kraegen EW. Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance. Diabetes 2009;58(3):550-8. 

  46. McGarry JD, Brown NF. The mitochondrial carnitine palmitoyl transferase system. From concept to molecular an alysis. Eur J Biochem 1997;15:1-14. 

  47. chwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000;404:661-71. 

  48. Rosen ED, Walkey CJ, Puigserver P and Spiegelman BM. Transcriptional regulation of adipogenesis. Genes Dev. 2000;14:1293. 

  49. Horton JD. Sterol regulatory element-binding proteins : transcriptional activators of lipid synthesis. Biochem. Soc.Trans. 2002;30:1091. 

  50. Rodriguez-Cantu LN, Gutierrez-Uribe JA, Arriola-Vucovich J, Diaz-De La Garza RI, Fahey JW, Serna-Saldivar SO. Broccoli (Brassica oleracea var. italica) sprouts and extracts rich in glucosinolates and isothiocyanates affect cholesterol metabolism and genes involved in lipid homeostasis in hamsters. J. Agr. Food Chem. 2011;59:1095-103. 

  51. KIM JB, Spiegelman BM. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev. 1996;10:1096-107. 

  52. Horton JD. Sterol regulatory element-binding proteins : transcriptional activators of lipid synthesis. Biochem. Soc. Trans. 2002;30:1091. 

  53. Endo A. The discovery and development of HMG-CoA reductase inhibitors. J. Lipid Res. 1992;33:1569-82. 

  54. Pal S, Ho N, Santos C, Dubois P, Mamo J, Croft K, Allister E. Red wine polyphenolics increase LDL receptor expression and activity and suppress the secretion of ApoB100 from human HepG2 cells. J. Nutr. 2003;133: 700-6. 

  55. Agheli N, Kabir M, Berni-Canani S, Petitjean E, Boussairi A, Luo J, Bornet F, Slama G, Rizkalla SW. Plasma lipids and fatty acid synthase activity are regulated by short-chain fructo-oligosaccharides in sucrose-fed insulin- resistant rats. J. Nutr. 1998;128:1283-8. 

  56. Shimano H. SREBPs: Physiology and pathophysiology of the SREBP family. FEBS J. 2009;276:616-21. 

  57. Park SJ, Lee IS, Lee SP, Yu MH. Inhibition of adipocyte differentiation and adipogenesis by supercritical fluid extracts and marc from Cinnamomum verum. J Life Sci 2013;23:510-7. 

저자의 다른 논문 :

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로